RPL35AP10

Across TCGA pan-cancer cohorts, RPL35AP10 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of RPL35AP10’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where RPL35AP10 RNA is repressed in tumor relative to normal tissue. In most cancer types RPL35AP10 is over-expressed in tumor, although a few such as KIRP and THCA show the opposite, repressed pattern.

KIRP, UCEC, and BLCA are the cancer types where RPL35AP10 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPL35AP10 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRP	All	All	−0.088	.011	4	view →
UCEC	All	IV	+0.405	.032	2	view →
BLCA	All	All	+0.226	.039	2	view →
THCA	All	All	−0.087	.003	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

RPL35AP10–KIRP

Open the KIRP breakdown →